THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 145 filers reported holding THERAPEUTICSMD INC in Q4 2018. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $62,000 | -37.4% | 83,305 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $99,000 | -11.6% | 83,305 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $112,000 | +10.9% | 83,305 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $101,000 | -23.5% | 83,305 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $132,000 | +26.9% | 83,305 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $104,000 | +18.2% | 83,305 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $88,000 | -56.4% | 83,305 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $202,000 | -33.1% | 83,305 | 0.0% | 0.00% | -40.0% |
| Q3 2019 | $302,000 | +39.2% | 83,305 | 0.0% | 0.01% | +66.7% |
| Q2 2019 | $217,000 | -46.6% | 83,305 | 0.0% | 0.00% | -40.0% |
| Q1 2019 | $406,000 | +28.1% | 83,305 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $317,000 | -41.9% | 83,305 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $546,000 | +27.0% | 83,305 | +21.0% | 0.01% | +25.0% |
| Q2 2018 | $430,000 | +54.1% | 68,841 | +20.3% | 0.00% | +33.3% |
| Q1 2018 | $279,000 | – | 57,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,660,108 | $60,749,000 | 7.08% |
| VHCP Management, LLC | 846,500 | $4,410,000 | 2.37% |
| Broadfin Capital, LLC | 2,128,159 | $11,088,000 | 1.46% |
| OUTFITTER ADVISORS, LTD. | 333,484 | $1,737,000 | 0.69% |
| GILDER GAGNON HOWE & CO LLC | 7,547,644 | $39,323,000 | 0.56% |
| Granite Point Capital Management, L.P. | 240,000 | $1,250,000 | 0.21% |
| EAM Investors, LLC | 221,885 | $1,156,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 135,208 | $704,000 | 0.14% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 70,000 | $365,000 | 0.06% |
| GAM Holding AG | 427,450 | $2,227,000 | 0.04% |